Given the paucity of reliable peripheral biomarkers of disease activity, our findings suggest that the frequency of CD25low HELIOS+FOXP3+ Tregs could provide valuable information about recent or ongoing tissue inflammation and could have a clinical application for the stratification of patients with autoimmunity. This evidence concerns the gene FOXP3 and Autoimmunity.